Regulators officially approved 30 more funds last month, with more expected authorizations in 2026. Will financial advisors and their clients bite?
As adoption of the dual-wrapper products accelerates, so will questions about timing, pricing and residual balances.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results